IPO Lens Logo
IPO LensSmarter IPO Research
Explore IPOs →
Back to Live IPOs
Symbiotec Pharmalab

Symbiotec Pharmalab

MAINBOARDNSEBSE
Issue Size₹1757 CrBook Built
Open Date24 Aug 2026Monday
Close Date27 Aug 2026Thursday
GMP Today
₹150+15.2% Premium
Price Band
₹938 - ₹988Per Share
Lot Size
TBAMinimum Lot
Min. InvestmentTBARetail (Min.)
Listing Date01 Sep 2026Tuesday
32/100
Weak Research

Weak fundamentals and premium/expensive valuation

Plain-English Summary

What does the company do?

Why are investors interested?

Strong business model in a growing sector with favorable industry drivers.

What should beginners watch out for?

Evaluate market volatility and competitive risks.

Key IPO Metrics

GMP Today

150Strong

+15.2%

Total Subscription

0.00x

Overall demand

Retail Subscription

0.00x

Retail Queue

QIB Subscription

0.00x

Institutional Queue

NII (HNI) Subscription

0.00x

Non-Institutional

Anchor Book

100%

Subscribed

Listing Date (Tentative)01 Sep 2026
Expected Listing SentimentNeutral
Face Value10
No. of Shares Offered1.78 Cr
Issue TypeBook Built

Business Overview

About the Company

Industry

Vibrant growth sector

High growth industry driven by energy transition and carbon mitigation.

+ Favourable Outlook

Business Segments (FY24)

Total Revenue₹1405.60 Cr
Core Operations
70%
Services & Maintenance
20%
Others
10%

Objects of the Issue

    Promoters

    Promoters group details

    Promoter Group holds 72.21% of pre-issue capital.

    Lead Managers

    Registrar

    TBA

    Financials & Performance(Standalone)

    Valuation & Peer Comparison

    CompanyP/E (x)ROE (%)Revenue CAGR (3Y)EBITDA Margin (%)Market Cap (₹ Cr)
    Symbiotec Pharmalab (IPO)----------

    Why this IPO looks good

    • Strong sector headwinds and rising demand
    • Consistent historical financials and profit margins
    • Experienced promoter group and management team

    Key risks to know

    • Working capital requirements are high
    • Raw material cost volatility could impact margins
    • Intense competition from unorganized players

    GMP Trend

    GMP Trend (₹)

    AI Research Q&A

    Who is this IPO suitable for?

    Ideal for investors who:

    • Believe in India's renewable energy growth story
    • Have a medium to long-term investment horizon
    • Are comfortable with moderate to high risk appetite
    Suitable
    Long Term InvestorsGrowth SectorsModerate Risk Appetite
    Last Updated: 19 Aug 2026, 06:24 AM
    Source: automated_sync_engineConfidence: MEDIUM